Project-level governance view
NeoLiver Platform
Structured translational review for one program.
This is the drilldown surface from the deck translated into product form: domain scores, mitigation context, milestone posture, and governance blockers in one place.
Current TRI
Acceleration candidate
77
Program shows strong technical momentum and credible commercial interest, but governance maturity is still below the threshold for clean external acceleration. Recommend limited advancement after IP and regulatory materials are completed.
- Regulatory narrative
- Board packet draft
Domain breakdown
Readiness is uneven, not binary.
Programs should be understood as strong in some domains and blocked in others. That is what the sandbox now shows from the actual demo analysis endpoint.
Milestones
Governance and execution status
This fixes the earlier milestone shape mismatch and shows a stable object model that can evolve cleanly once private data replaces the demo dataset.
Milestone Status Signal Context
Evidence normalization
In progress
7 days late
Artifacts are scattered across research and grant folders.
Regulatory narrative
Blocked
Awaiting owner input
Submission sequencing still needs named owners and target claims.
Board packet draft
Queued
Due this week
Committee-facing materials need the latest TRI narrative and mitigation plan.
Investor diligence summary
Not started
Acceleration candidate if unlocked
Commercial story is strong enough to package once governance gaps close.
Mitigations
Action path before external acceleration
The TRI view is only useful if it drives mitigation work. These items come from the deployed AI worker demo endpoint.
- Complete IP packaging and freedom-to-operate review before investor outreach.
- Tighten the regulatory sequencing narrative into a board-ready summary.
- Normalize evidence artifacts into one committee packet before stage-gate review.